Compare Alcon AG (ALC) vs Moody's Corporation (MCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Moody's Corporation — how do they compare? Alcon AG trades at $73.99 (market cap $36.44B), while Moody's Corporation trades at $479.75 (market cap $82.52B). The key difference: Moody's Corporation is far larger — about 2.3× Alcon AG's market cap, and Moody's Corporation pays the higher dividend (0.86%). Which is the better fit depends on your goals.
| ALC | MCO | |
|---|---|---|
Market Cap | $36.44B | $82.52B |
Sector | Health | Financials |
52-Week High | $90.12 | $539.61 |
52-Week Low | $62.02 | $412.23 |
Enterprise Value | $40.28B | $88.54B |
Dividend Yield | 0.48% | 0.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $73.59, down slightly by 0.05% today, with a bullish technical signal from moving averages and a consensus analyst price target of $86.67 implying 17.8% upside. Recent Q2 2026 earnings beat estimates with EPS of $0.84 versus $0.77 expected, and the company raised its 2026 profitability outlook, driving positive investor sentiment. Revenue growth has been steady, reaching $10.40 billion in 2025, though net income margin dipped to 5.92%.
The outlook is positive given strong earnings beats, raised guidance, and bullish analyst ratings, but risks include elevated P/E of 57.52, high RSI levels suggesting overbought conditions, and margin pressures from rising costs. Institutional ownership trends and recent collaborations, like with RxSight, support growth, yet macroeconomic and competitive factors warrant caution.
MCO trades at $477.84, showing minimal daily movement (-0.06%) amid a bearish technical signal. The company demonstrates strong fundamentals with 15% revenue growth in Q2 2026 and consistent earnings beats, achieving a 34.25% net income margin. Recent news highlights institutional repositioning into credit rating companies, with MCO benefiting from robust debt issuance and AI-related analytics demand.
Outlook remains positive with a $561.88 consensus price target (17.6% upside), though valuation multiples appear elevated. Key risks include competitive pressures and market sensitivity to credit cycles. The combination of strong profitability, analyst support (56% buy ratings), and strategic positioning in credit analytics supports a constructive view despite technical headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →
